Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.11 USD | +7.07% | +38.88% | +404.58% |
09/07 | Emergent Biosolutions, Johnson & Johnson Settle Dispute Over COVID-19 Vaccine Manufacturing | MT |
08/07 | Emergent, J&J settle COVID vaccine supply deal dispute | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+404.58% | 635M | |
+61.53% | 848B | |
+38.95% | 627B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+5.89% | 234B | |
+16.53% | 225B | |
+15.67% | 179B | |
+2.47% | 167B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Transcript : Emergent BioSolutions, Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-14-2014 09